Mark Aleynick

1.9k total citations
5 papers, 96 citations indexed

About

Mark Aleynick is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Mark Aleynick has authored 5 papers receiving a total of 96 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Immunology and 1 paper in Genetics. Recurrent topics in Mark Aleynick's work include Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (4 papers) and CAR-T cell therapy research (4 papers). Mark Aleynick is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (4 papers) and CAR-T cell therapy research (4 papers). Mark Aleynick collaborates with scholars based in United States, Sweden and Germany. Mark Aleynick's co-authors include Judit Svensson‐Arvelund, Joshua Brody, Christopher R. Flowers, Aurélien Marabelle, Brian D. Brown, Miriam Mérad, Linda Hammerich, Ranjan Upadhyay, Michael Yellin and Christine Moussion and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

Mark Aleynick

5 papers receiving 95 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Aleynick United States	4	73	52	29	17	7	5	96
Mercedes Lewandrowski United States	2	84 1.2×	47 0.9×	23 0.8×	5 0.3×	3 0.4×	2	125
Andrew W. Daman United States	6	76 1.0×	77 1.5×	64 2.2×	32 1.9×	3 0.4×	12	149
Kaspar Bresser Netherlands	4	100 1.4×	41 0.8×	25 0.9×	12 0.7×	5 0.7×	10	127
Yohan Gerber-Ferder France	3	120 1.6×	37 0.7×	39 1.3×	8 0.5×	7 1.0×	4	148
Alexander Wintges Germany	5	159 2.2×	68 1.3×	86 3.0×	16 0.9×	5 0.7×	10	204
Gabriele De Simone Italy	5	98 1.3×	94 1.8×	36 1.2×	17 1.0×	3 0.4×	6	153
Patrick Layritz Germany	3	93 1.3×	108 2.1×	26 0.9×	17 1.0×	5 0.7×	4	144
Viola Katharina Vetter Switzerland	3	59 0.8×	58 1.1×	18 0.6×	6 0.4×	4 0.6×	8	92
Katja Petry Germany	3	111 1.5×	78 1.5×	51 1.8×	3 0.2×	4 0.6×	4	127

Countries citing papers authored by Mark Aleynick

Since Specialization

Citations

This map shows the geographic impact of Mark Aleynick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Aleynick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Aleynick more than expected).

Fields of papers citing papers by Mark Aleynick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Aleynick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Aleynick. The network helps show where Mark Aleynick may publish in the future.

Co-authorship network of co-authors of Mark Aleynick

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Aleynick. A scholar is included among the top collaborators of Mark Aleynick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Aleynick. Mark Aleynick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Aleynick, Mark, Judit Svensson‐Arvelund, Samuel A. Rose, et al.. (2023). Pattern recognition receptor agonists in pathogen vaccines mediate antitumor T-cell cross-priming. Journal for ImmunoTherapy of Cancer. 11(7). e007198–e007198. 3 indexed citations

2.

Svensson‐Arvelund, Judit, Mark Aleynick, Linda Hammerich, et al.. (2022). Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity. Nature Communications. 13(1). 7149–7149. 38 indexed citations

3.

Marron, Thomas U., Mark Aleynick, Linda Hammerich, et al.. (2019). Antitumor T-cell Homeostatic Activation Is Uncoupled from Homeostatic Inhibition by Checkpoint Blockade. Cancer Discovery. 9(11). 1520–1537. 13 indexed citations

4.

Aleynick, Mark, Judit Svensson‐Arvelund, Christopher R. Flowers, Aurélien Marabelle, & Joshua Brody. (2019). Pathogen Molecular Pattern Receptor Agonists: Treating Cancer by Mimicking Infection. Clinical Cancer Research. 25(21). 6283–6294. 41 indexed citations

5.

Aleynick, Mark, Linda Hammerich, Ranjan Upadhyay, et al.. (2018). Natural pattern-recognition-receptor agonists as adjuvants for in situ vaccination lymphoma immunotherapy.. Journal of Clinical Oncology. 36(5_suppl). 123–123. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact